Avenue Capital Group

Voom Medical Devices specializes in manufacturing innovative orthopedic medical devices and appliances, primarily focused on minimally invasive surgery for the foot and ankle. Their flagship products include orthopedic devices designed to surgically repair bunions while preserving a range of motion, enhancing patients' quality of life. Additionally, they provide tools for healthcare professionals to improve surgical efficiency.

Spectral AI, Inc. is a predictive analytics company focused on advancing wound care through its proprietary AI algorithms and optical technology. The company has developed the DeepView® Wound Imaging Solution, a multispectral imaging system that has received FDA Breakthrough Designation for burn indications. This innovative technology enables the differentiation between non-healing and healing human tissue that is not visible to the naked eye. By providing 'Day One' healing assessments for burn wounds and diabetic foot ulcers, Spectral AI aims to assist clinicians in making more accurate and timely treatment decisions, ultimately enhancing patient care in the wound care sector.

Proscia Inc. is a Philadelphia-based company that develops a cloud-based digital pathology platform aimed at enhancing cancer diagnosis and improving patient outcomes. Founded in 2014, Proscia's platform leverages advanced computing technologies to analyze data that is not perceptible to the human eye. By transforming this hidden data into actionable insights, the platform supports routine pathology operations and aids physicians in accelerating the development of life-saving medical advancements.

CalciMedica, Inc. is a clinical-stage biopharmaceutical company based in La Jolla, California, specializing in the discovery and development of small molecule drugs aimed at treating autoimmune and inflammatory diseases. Founded in December 2006 by a team of scientists with backgrounds in the field, the company focuses on the specific inhibition of calcium release-activated calcium channels. This innovative approach seeks to modulate the immune response and protect against tissue cell injury, addressing significant unmet medical needs in life-threatening inflammatory conditions for which existing therapies are lacking. CalciMedica's proprietary technology has the potential to offer therapeutic benefits in these challenging areas of healthcare.

Men in Blazers is a U.S.-based media company specializing in soccer coverage. It produces engaging content, including podcasts and TV shows, focused on major international leagues like the Premier League and Champions League, as well as U.S. national teams and the National Women's Soccer League. The company is known for its unique blend of humor, emotion, intelligence, and pop culture references in its coverage.

Mercury/13, established in 2023, is a private equity firm specializing in acquiring equity stakes in European professional women's football teams. Its primary objective is to become a leading force in women's football ownership by strategically investing in and supporting the growth of future powerhouse clubs, thereby tapping into the vast, underserved market of women's football fans.

Unrivaled is a professional women's basketball league that focuses on creating competitive opportunities for female athletes. The league offers an innovative platform that serves as a viable alternative for women players seeking competition and income during the off-season of the WNBA. By organizing three versus three matches, Unrivaled aims to enhance the visibility of women's basketball while providing an engaging format for both players and fans.

Ocugen, Inc. is a clinical-stage biopharmaceutical company based in Malvern, Pennsylvania, dedicated to discovering, developing, and commercializing innovative therapies aimed at curing blinding diseases. The company's pipeline includes several promising product candidates, such as OCU200, a novel fusion protein in preclinical development for treating wet age-related macular degeneration (AMD), diabetic retinopathy, and diabetic macular edema. Additionally, Ocugen is developing OCU400 for retinitis pigmentosa, a rare genetic disorder, and OCU410 for dry AMD. The company utilizes its Modifier Gene Therapy Platform to address unmet medical needs in the field of retinal diseases, including inherited conditions and multifactorial diseases. Ocugen has also established a strategic partnership with CanSino Biologics Inc. for the co-development and manufacturing of gene therapies.

Epica International, Inc. specializes in designing, developing, and distributing advanced robotic systems aimed at enhancing precision and outcomes in various medical fields. The company's product lineup includes Vimago, a CT imaging and fluoroscopy device for veterinary diagnostics; Pegaso, a high-definition CT system for equine veterinary applications; and Artemis, a device for non-invasive regenerative therapy in animals. Additionally, Epica offers Ortis, a carving robotic system for orthopedic applications, and SandRob, a surface processing system for detailed finishing needs. Their ScultoRob system is designed for milling artistic and architectural designs, while ARPP serves as a robotic simulation software for control and programming. Founded in 2013 and based in San Clemente, California, Epica International aims to integrate precision robotics with imaging technologies to improve diagnostic and therapeutic capabilities in veterinary medicine, orthotics, and surface processing markets.

Cosm is a technology, media, and entertainment company that specializes in creating comprehensive solutions for immersive experiences across various sectors. The company develops a global platform that integrates physical design, engineering, manufacturing, software, and content delivery, enabling large-scale, live immersive entertainment. By focusing on areas such as sports, education, and attractions, Cosm aims to transform how individuals engage with entertainment through innovative technologies and experiences.

Cytosorbents Corporation is a medical device company specializing in blood purification technologies to treat life-threatening conditions in critical care settings. The company's flagship product, CytoSorb, is an extracorporeal cytokine filter designed to reduce inflammation and prevent organ failure in patients suffering from conditions such as sepsis and trauma. Cytosorbents also develops various other devices, including VetResQ for veterinary applications, HemoDefend for blood supply purification, K+ontrol for severe hyperkalemia, and ContrastSorb to mitigate contrast-induced nephropathy. The company utilizes proprietary biocompatible polymer technology to effectively remove toxic substances from blood and other bodily fluids. With a primary revenue stream from product sales in Europe, particularly Germany, Cytosorbents also receives funding from grant agencies in the United States. Founded in 1997 and based in Monmouth Junction, New Jersey, Cytosorbents aims to enhance patient outcomes in intensive care and cardiac surgery through innovative blood purification solutions.

NSP is a restaurant brand that specializes in providing franchising solutions for Burger King, KFC, and other fast-food restaurants.

PolarityTE, Inc. is a clinical-stage biotechnology company specializing in regenerative medicine and the development of innovative tissue products and biomaterials. Based in Salt Lake City, Utah, the company focuses on creating functionally polarized human tissues to enhance clinical outcomes and support biomedical research. Its flagship product, SkinTE, utilizes a patient's own tissue to facilitate the regeneration of skin for individuals with acute and chronic wounds, burns, and other skin-related conditions. By employing a method that promotes the natural healing process, PolarityTE aims to transform tissue engineering through its technology platform, which simplifies the regeneration of various cells and tissues. Founded in 2015, the company is dedicated to improving patient care and outcomes by leveraging the body's innate healing capabilities.

ProducePay, founded by Pablo Borquez Schwarzbeck, aims to revolutionize the global fresh produce supply chain by addressing the challenges of economic and food waste. This AgTech company has developed a Predictable Commerce Platform that enhances the connection between growers and buyers, offering access to capital, trading opportunities, insights, and improved supply chain visibility. By providing farmers with immediate liquidity and financing options, along with real-time pricing data, ProducePay enables them to make informed decisions and expand their businesses. This platform not only facilitates efficient transactions but also ensures that consumers receive fresher produce while promoting sustainable practices within the agricultural industry.

ITS Technology Group Limited is a telecommunications and IT services provider based in Chester, United Kingdom, with additional offices in Cleveland, Glasgow, West Yorkshire, and Powys. Established in 2013, the company specializes in delivering internet and managed IT services to rural and urban businesses, communities, and regions. Its offerings include a range of broadband solutions such as wireless WAN, full fiber services, and WiFi hotspots, alongside telecommunications services like VoIP and business lines. Additionally, ITS provides managed IT services encompassing Microsoft Office 365, cloud storage, LAN infrastructure, and consultancy. The company focuses on enhancing connectivity and operational efficiency for both private and public sector organizations through strategic partnerships.

Beyond Air, Inc. is a clinical-stage medical device and biopharmaceutical company based in Garden City, New York, focused on developing inhaled nitric oxide (NO) therapies for respiratory infections and solid tumors. The company is advancing its proprietary LungFit system, a nitric oxide generator and delivery device designed to provide precise amounts of NO to patients, whether intubated or non-intubated, in both hospital and home settings. This innovative technology generates nitric oxide from ambient air, allowing for continuous or intermittent delivery and enabling on-demand titration. Beyond Air aims to transform the treatment landscape for respiratory conditions, targeting various ailments such as lung infections, persistent pulmonary hypertension in newborns, and severe respiratory illnesses. Founded in 2011, the company strives to improve patient outcomes while addressing the need to eliminate traditional gas cylinders from medical environments.

Eyenovia, Inc. is a clinical stage ophthalmic biopharmaceutical company based in New York, focused on developing innovative microdose therapeutics through its proprietary piezo-print delivery technology known as the Optejet. The company's aim is to enhance the delivery of ophthalmic pharmaceuticals by replacing traditional eye dropper methods, thereby improving safety, tolerability, and patient compliance for various eye treatments. Eyenovia's product pipeline includes several candidates: MicroLine, currently in Phase III development for presbyopia; MicroProst, also in Phase III trials for chronic angle closure glaucoma and ocular hypertension; MicroStat, which has completed Phase III trials for mydriasis; MicroTears for red eye and itch relief; and MicroPine for progressive myopia. The company seeks to address indications that lack FDA-approved drug therapies and was established in 2014, originally as PGP Holdings V, Inc., before rebranding to Eyenovia.

Kin Insurance, Inc. is a digital insurance agency specializing in homeowners insurance and related products, including mobile home, condo, flood, manufactured home, landlord, umbrella, hurricane, wildfire, and second home insurance. Founded in 2016 and headquartered in Chicago, Illinois, with an additional office in St. Petersburg, Florida, Kin Insurance operates payment processing offices in Palatine and Chicago. By eliminating external agents, Kin Insurance offers a direct-to-consumer model that enhances the convenience and affordability of homeowners insurance. The company's technology platform provides a seamless user experience, personalized coverage options, and efficient claims processing. Kin leverages extensive property data to deliver precise pricing and improve underwriting outcomes.

Oliver Space is a home furnishing company founded in 2018 in San Francisco, California, by Chan Park. The company specializes in providing a wide range of furniture and home decor products, including sofas, rugs, pillows, and plants, through an online platform. Oliver Space offers customers flexible payment options, allowing them to either rent or purchase items on a monthly subscription basis. This model enables individuals to create aesthetically pleasing living spaces without the burden of high upfront costs. Additionally, customers can enjoy a trial period before committing to a purchase, with the option of 0% interest financing, making home decoration both easy and affordable.

Enerkem Inc. is a cleantech company based in Montreal, Canada, specializing in the production of renewable biofuels and chemicals derived from waste materials. The company utilizes a proprietary thermochemical process to convert non-recyclable municipal solid waste into cellulosic ethanol and other renewable chemicals. Over a decade of research has validated Enerkem's technology, which addresses issues related to oil dependence and waste disposal. The company operates advanced facilities that support its business model of producing biofuels profitably from a diverse range of feedstocks. Enerkem is majority-owned by a mix of institutional and clean-technology investors, including various venture capital firms and industrial investors. With a workforce of approximately 170 employees across Canada and the United States, Enerkem is committed to transforming waste into sustainable energy solutions.

Aytu Biopharma is a specialty pharmaceutical company focused on developing and commercializing products for various healthcare conditions. The company primarily targets urological indications, with an emphasis on male sexual dysfunction and male infertility, while exploring opportunities in other related areas. In addition to its urological focus, Aytu Biopharma offers prescription therapeutics for attention deficit hyperactivity disorder and other common pediatric conditions. The company is also advancing a therapeutic pipeline that includes AR101/enzastaurin, a prospective treatment for vascular Ehlers-Danlos Syndrome, a rare genetic disorder characterized by serious health complications. This treatment has received Orphan Drug designation from the FDA, highlighting its potential importance in addressing unmet medical needs. Aytu Biopharma’s diverse portfolio reflects its commitment to improving patient outcomes across various therapeutic areas.

Intellihot specializes in the manufacture of tankless water heating systems tailored for both residential and commercial use. Founded in 2005, the company emerged from a practical need when a traditional water heater malfunctioned, leading to significant water damage. Intellihot's systems are designed to conserve space by eliminating the need for bulky storage tanks, and they incorporate advanced technology, including Wi-Fi and 3G/4G connectivity. This connectivity allows users to monitor and analyze water usage patterns, providing an efficient on-demand heating solution that optimizes performance and resource use. The innovative design of Intellihot's products has garnered recognition and includes several patents pending.

BioVie Inc. is a clinical-stage biotechnology company based in Santa Monica, California, focused on discovering, developing, and commercializing innovative drug therapies for chronic and debilitating conditions, particularly liver disease and neurological disorders. Founded in 2013 and previously known as NanoAntibiotics, Inc., BioVie is advancing its lead product, BIV201, which has completed a Phase 2a clinical trial aimed at treating ascites resulting from chronic liver cirrhosis. Additionally, the company is conducting a pivotal Phase 3 study of NE3107 to assess its efficacy in patients with mild to moderate Alzheimer's disease. BioVie aims to improve the health and quality of life for patients through its targeted therapies.

Netomnia is a fiber-to-the-premises (FTTP) broadband service provider based in London, England, established in 2019. The company focuses on constructing full-fiber broadband infrastructure and networks throughout the United Kingdom, delivering symmetrical multi-gigabit services. This approach enables both residential and business clients to access reliable internet speeds tailored to their specific requirements.

Delcath Systems, Inc. is an interventional oncology company based in New York that specializes in the treatment of primary and metastatic liver cancers. The company's primary product is Melphalan Hydrochloride for Injection, which is used in conjunction with the Delcath Hepatic Delivery System to deliver high-dose chemotherapy directly to the liver while minimizing systemic exposure and side effects. Delcath is currently conducting Phase III clinical trials, including the FOCUS Trial for patients with hepatic dominant ocular melanoma and the ALIGN Trial for intrahepatic cholangiocarcinoma. Additionally, Delcath offers Melphalan Hydrochloride under the Delcath Hepatic CHEMOSAT Delivery System in Europe. Founded in 1988, Delcath Systems is dedicated to advancing treatment options for patients with liver cancer.

Cytocom, Inc. a specialty biotech company, founded by patients, specializing in repurposing of drugs that deploys their patented therapies focused on the activation and rebalancing of the body’s immune system. Stimulating the body’s immune system remains one of the most promising approaches in the treatment of Cancers, HIV, Autoimmune Diseases, inflammatory conditions and other chronic infectious diseases.

Third Pole Therapeutics, based in Waltham, Massachusetts, specializes in developing innovative, on-demand nitric oxide delivery systems for various medical applications. Their core technology generates pure, inhalable nitric oxide from air and electricity, eliminating the need for bulky gas cylinders. This system is equivalent to traditional tank-gas methods and has proven effective in treating hypoxic respiratory failure in newborns. The company aims to expand the accessibility of nitric oxide therapy, which is currently limited to certain countries and healthcare settings, to save lives and improve patient outcomes in conditions like malaria, heart attacks, and strokes.

Zorin Finance is a real estate lender established in 2011 and headquartered in London, United Kingdom. The company specializes in offering development finance and bridge loans specifically tailored for real estate developers operating within the UK market. By focusing on the needs of the real estate sector, Zorin Finance aims to support developers in achieving their project goals through accessible and targeted financial solutions.

Castlehaven Finance is an alternative lender that focuses on funding property development projects in Ireland. The company provides a range of lending services, including senior development loans, bridge finance, and financing for residential, commercial, and mixed-use developments. By offering flexible and reliable loan solutions, Castlehaven Finance supports private, social, and commercial projects, helping clients secure the necessary funding to bring their developments to fruition.

Asset Reconstruction Company (India) Ltd. is a Mumbai-based entity specializing in asset reconstruction and management services. The company focuses on the acquisition of non-performing financial assets from Indian banks and financial institutions, facilitating the resolution of significant amounts of Non-Performing Assets (NPAs). By establishing trusts and special purpose vehicles (SPVs), it assists these institutions in maintaining liquidity and operational efficiency, thereby enabling them to achieve their financial objectives. Since its inception, Asset Reconstruction Company has successfully resolved over Rs. 780 billion worth of NPAs, positioning itself as a key player in the financial services sector in India.

Owns and operates a coal-fired power plant near Baltimore

Ambow Education Holding Ltd. is a prominent provider of educational and career enhancement services in the People's Republic of China. The company operates through two main segments: K-12 Schools and Career Programs and Continuing Education (CP&CE). The K-12 Schools segment offers educational services that encompass K-12 programs, tutoring, and international education. The CP&CE segment focuses on tutoring centers that provide classroom instruction, small group, and individualized tutoring to help students excel in their studies and prepare for critical examinations, such as high school and university entrance tests. Additionally, this segment offers educational software, career enhancement services, and training for both professional and soft skills, including leadership and interview techniques. As of December 31, 2019, Ambow operated 60 centers and schools, which included K-12 schools, tutoring centers, training offices, and career enhancement facilities. Founded in 2000 and headquartered in Beijing, Ambow aims to meet the growing educational demands of students and recent graduates in China.

Wuxi Qiaolian Wind Power Technology Co. Ltd. is a manufacturer based in Wuxi, China, established in 2006. The company specializes in producing components for wind power equipment, including rotor hubs, nacelle bases, girder systems, bearing cases, and pitch adjuster parts. In addition to its focus on wind power, Wuxi Qiaolian is involved in the research, design, and manufacturing processes of CNC and general-purpose machine tools, as well as metallurgical equipment. Through its diverse product offerings, the company aims to contribute to the renewable energy sector and enhance manufacturing capabilities in related industries.

Ambow Education Holding Ltd. is a prominent provider of educational and career enhancement services in the People's Republic of China. The company operates through two main segments: K-12 Schools and Career Programs and Continuing Education (CP&CE). The K-12 Schools segment offers educational services that encompass K-12 programs, tutoring, and international education. The CP&CE segment focuses on tutoring centers that provide classroom instruction, small group, and individualized tutoring to help students excel in their studies and prepare for critical examinations, such as high school and university entrance tests. Additionally, this segment offers educational software, career enhancement services, and training for both professional and soft skills, including leadership and interview techniques. As of December 31, 2019, Ambow operated 60 centers and schools, which included K-12 schools, tutoring centers, training offices, and career enhancement facilities. Founded in 2000 and headquartered in Beijing, Ambow aims to meet the growing educational demands of students and recent graduates in China.